Details of the Drug Reposition

General Information of This Drug (ID: DM0N85H)

Drug Name
Vidarabine   DM0N85H
Synonyms
Araadenosine; Arabinosyladenine; Armes; RAB; Spongoadenosine; VIRDARABINE; Vidarabin; Vidarabina; Vidarabinum; Xylosyladenine; Adenine arabinoside; Adenine xyloside; Adenosine arabinose; Ara A; Arabinoside adenine; Arabinosyl adenine; Vidarabina [DCIT]; Vidarabine anhydrous; Vira ATM; Xylosyl A; A 9251; ARA-A NSC 247519; Alpha-Ara A; Ara-A; Arabinosyl-adenine; Arasena-A; Armes (TN); Beta-Ara A; Vidarabine (JAN); Vira-A; Adenosine-8-14C; Vira-A, Vidarabine; ADENOSINE, U.S.P.; (+)-Cyclaradine; 9-Arabinosyladenine
Therapeutic Class
Antiviral Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
12 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Testicular lymphoma DISC2M2N N.A. Approved [1]
Splenic marginal zone lymphoma DISCGTZY N.A. Approved [1]
Small intestine lymphoma DISDOS6S N.A. Approved [1]
Primary cutaneous peripheral T-cell lymphoma not otherwise specified DIS5OHQF N.A. Approved [1]
MALT lymphoma DIS1AVVE N.A. Approved [1]
Hepatosplenic T-cell lymphoma DIS7KMY9 N.A. Approved [1]
Herpetic keratitis DISF3BXT 1F00.10 Approved [1]
Myeloproliferative neoplasm DIS5KAPA 2A20 Approved [1]
Recurrent adult burkitt lymphoma DIS6V60A 2A85.6 Approved [1]
Large granular lymphocytic leukemia DISHOPPI 2A90.1 Approved [1]
Lung cancer DISCM4YA 2C25.0 Approved [1]
Immunodeficiency DIS093I0 4A00-4A85 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Indications(s)
3 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Leukemia DISNAKFL N.A. Discontinued in Phase 2 [2]
Post-transplant lymphoproliferative disorder DISTS43D 2B32 Discontinued in Phase 2 [3]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
3 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric cancer DISXGOUK 2B72 Investigative [1]
Colon cancer DISVC52G 2B90.Z Investigative [1]
Neuroblastoma DISVZBI4 2D11.2 Investigative [1]
------------------------------------------------------------------------------------

References

1 Vidarabine FDA Label
2 Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
3 Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
4 Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia